despit
mani
promis
molecular
diagnost
would
transform
manag
infect
empir
therapi
remain
standard
care
communityacquir
pneumonia
cap
outsid
etiolog
studi
vast
major
patient
never
pathogen
diagnos
caus
pneumonia
although
physician
gener
quit
comfort
empir
therapi
need
guess
fear
miss
import
pathogen
inevit
lead
broader
necessari
spectrum
coverag
particularli
set
sever
ill
virus
import
caus
pneumonia
known
sinc
identif
influenza
earli
despit
awar
virus
caus
cap
recent
appear
footnot
list
common
pathogen
howev
modern
gener
diagnost
panel
particularli
nucleic
acid
amplif
test
viral
pathogen
identifi
increasingli
common
caus
cap
possibl
overal
common
bacteria
sensit
test
also
come
confirm
patient
cap
frequent
multipl
pathogen
present
particularli
combin
bacteri
viral
infect
term
atyp
pneumonia
coin
first
half
centuri
use
describ
pneumonia
owe
pathogen
detect
standard
gram
stain
tradit
cultur
method
typic
associ
headach
lowgrad
fever
cough
malais
predomin
pathogen
becom
associ
atyp
pneumonia
mycoplasma
pneumonia
first
identifi
human
lung
legionella
pneumophila
first
identifi
signific
pneumonia
pathogen
outbreak
convent
philadelphia
chlamydophila
pneumonia
first
identifi
respiratori
tract
varieti
differ
speci
genera
recogn
pneumonia
pathogen
review
cover
main
approach
diagnosi
atyp
viral
infect
set
pneumonia
common
approach
use
pathogenspecif
assay
use
urin
blood
sputum
although
serolog
test
base
detect
antibodi
specif
pathogen
predomin
techniqu
decad
limit
earli
diseas
adapt
immun
respons
constitut
well
issu
crossreact
reduc
specif
polymeras
chain
reaction
pcr
base
techniqu
primari
modal
detect
atyp
pathogen
set
recent
develop
multipathogen
detect
platform
becom
use
increasingli
set
pneumonia
move
laboratori
test
worth
briefli
look
evid
whether
specif
clinic
radiolog
featur
cap
help
deduc
reliabl
pathogen
definit
clinic
featur
seen
commonli
atyp
pathogen
diseas
owe
streptococcu
pneumonia
exampl
includ
erythema
multiform
pneumonia
diarrhea
l
pneumophila
rhinorrhea
influenza
howev
ampl
evid
set
clinic
symptom
sign
suffici
predict
abil
rule
atyp
viral
pathogen
especi
pneumonia
legionella
number
nonmicrobiolog
test
also
propos
abl
discrimin
atyp
typic
pathogen
includ
peripher
white
cell
count
procalcitonin
although
peripher
white
cell
count
tend
lower
viral
infect
compar
bacteri
infect
particularli
discrimin
individu
patient
level
certainli
accur
enough
use
determin
empir
therapi
procalcitonin
seem
accur
white
cell
count
discrimin
atyp
bacteri
infect
viral
infect
may
mislead
particularli
critic
ill
patient
patient
bacteri
viral
coinfect
definit
diagnosi
base
detect
infect
pathogen
therefor
remain
critic
improv
accuraci
empir
therapi
littl
chang
diagnosi
legionella
infect
sinc
review
topic
comprehens
year
ago
set
legionella
underdiagnos
therefor
underrecogn
owe
routin
test
perform
legionella
infect
seem
increas
unit
state
possibl
owe
recent
climat
chang
includ
number
sever
outbreak
multipl
fatal
led
increas
interest
diagnosi
legionella
grow
standard
cultur
media
diagnosi
tradit
rest
either
posit
serolog
posit
urinari
antigen
test
test
signific
limit
case
serolog
patient
cultureproven
legionella
infect
ever
seroconvert
seroconvers
may
take
month
requir
test
least
month
longer
urinari
antigen
test
quit
specif
reliabl
detect
l
pneumophila
serogroup
usual
serogroup
mani
area
speci
particularli
legionella
longbeacha
legionella
micdadei
predomin
despit
limit
urinari
antigen
test
legionella
recommend
patient
sever
cap
ie
admit
intens
care
unit
diagnost
public
health
reason
mainstay
diagnosi
legionella
infect
one
direct
antigen
detect
nucleic
acid
detect
respiratori
secret
direct
fluoresc
antigen
detect
develop
prepcr
era
larg
replac
pcr
latter
sensit
less
technician
depend
easier
autom
pcr
test
legionella
mix
homegrown
assay
commerci
avail
product
report
sensit
specif
use
test
gold
standard
rang
respect
pcr
test
legionella
gener
abl
detect
speci
surprisingli
greater
degre
sensit
urinari
antigen
test
howev
reason
argument
perform
urinari
antigen
test
pcr
respiratori
secret
increas
diagnost
yield
approach
worth
note
nasopharyng
aspir
throat
swab
substanti
lower
yield
detect
legionella
pcr
may
use
patient
possibl
get
spontan
induc
sputum
sampl
tradit
mycoplasma
infect
often
diagnos
basi
serolog
howev
serolog
test
mani
pathogen
signific
limit
earli
diseas
falseneg
result
common
difficulti
make
diagnosi
well
mark
season
season
variat
preval
probabl
explain
enorm
variat
estim
proport
case
cap
owe
pneumonia
rang
less
greater
pcr
overcom
limit
serolog
diagnosi
mycoplasma
infect
nuanc
assay
develop
rel
perform
characterist
review
comprehens
elsewher
perform
characterist
pcr
assay
pneumonia
seem
least
good
legionella
infect
possibl
better
pathogen
detect
rate
pneumonia
use
pcr
nasopharyng
aspir
lower
sputum
sampl
recent
interest
antigen
detect
assay
diagnosi
pneumonia
offer
potenti
pointofcar
test
far
yet
enter
clinic
mainstream
chlamydophila
nomenclatur
chlamydia
chang
recent
chlamydia
chlamydophila
combin
back
singl
genu
chlamydia
psittaci
c
pneumonia
wellaccept
caus
cap
although
almost
alway
identifi
much
less
common
either
mycoplasma
legionella
infect
number
chlamydophilalik
pathogen
parachlamydia
acanthamoeba
simkania
negevensi
also
suggest
potenti
caus
case
cap
pathogen
identifi
specif
posit
serolog
c
pneumonia
also
question
studi
use
pcrbase
diagnosi
typic
find
much
lower
rate
infect
earlier
serologybas
studi
larg
varieti
assay
differ
perform
characterist
use
mycoplasma
earli
diseas
chlamydophila
serolog
often
neg
make
pcr
superior
diagnost
test
unlik
legionella
mycoplasma
chlamydophila
detect
pcr
assay
cultur
chlamydophila
difficult
low
yield
rare
done
therefor
pcr
assay
develop
gener
compar
serolog
test
known
limit
discuss
true
sensit
pcr
chlamydophila
speci
therefor
unknown
howev
report
specif
assay
well
therefor
posit
result
right
clinic
context
act
major
etiolog
studi
cap
identifi
influenza
signific
caus
cap
particularli
hospit
patient
sinc
recent
influenza
pandem
evid
use
empir
antiinfluenza
therapi
set
cap
increas
significantli
unclear
impact
outcom
fast
reliabl
diagnost
test
influenza
therefor
attract
prescrib
antivir
appropri
treatment
prophylaxi
also
aid
alloc
respiratori
isol
bed
often
limit
suppli
especi
influenza
season
reason
diagnost
tool
avail
influenza
significantli
outpac
caus
atyp
pneumonia
unit
state
dozen
approv
rapid
influenza
test
primarili
base
detect
influenza
antigen
respiratori
sampl
avail
assay
compar
gold
standard
realtim
revers
transcript
pcr
sampl
sensit
assay
vari
depend
age
qualiti
sampl
durat
symptom
complic
assess
use
assay
perform
seem
vari
influenza
strain
unfortun
pandem
less
optim
recent
metaanalysi
publish
studi
rapid
influenza
test
found
pool
sensit
sensit
specif
posit
neg
predict
valu
respect
surprisingli
given
data
littl
evid
rapid
influenza
test
current
use
clinician
alter
patient
manag
howev
rapidli
chang
field
recent
public
suggest
increment
improv
rang
sensit
specif
clearli
area
expect
see
signific
advanc
next
year
absenc
rapid
diagnost
test
exist
commerci
pcr
assay
influenza
welldocu
good
perform
characterist
influenza
b
data
wellreview
elsewher
interest
etiolog
studi
high
degre
copathogen
involv
influenza
particularli
codetect
bacteri
infect
pneumonia
whether
genuin
coinfect
sequenti
infect
current
controversi
major
area
research
interest
unlik
bacteri
pathogen
constant
genom
shift
influenza
affect
perform
assay
need
revalid
constantli
new
strain
appear
varieti
pointofcar
platform
develop
detect
influenza
genexpert
system
cepheid
sunnyval
ca
perhap
far
best
studi
genexpert
allinon
platform
requir
minim
technic
expertis
potenti
pointofcar
platform
diagnos
influenza
sputum
sampl
place
cartridg
plug
platform
without
need
process
expert
microbiolog
assist
turnaround
time
less
hour
result
avail
fast
enough
impact
empir
therapi
system
evalu
extens
diagnosi
tuberculosi
includ
multidrugresist
tuberculosi
proven
excel
sensit
specif
influenza
b
genexpert
assay
evalu
comparison
number
commerci
avail
rapid
antigen
test
pcr
test
found
excel
sensit
specif
potenti
clinic
use
studi
emerg
depart
set
good
perform
effici
pointofcar
test
influenza
highli
competit
area
potenti
new
product
regularli
enter
market
offer
greater
speed
lower
cost
andor
greater
accuraci
exampl
larg
number
virus
wellknown
caus
pneumonia
common
adenoviru
respiratori
syncyti
viru
metapneumonviru
parainfluenza
coronavirus
absenc
specif
treatment
virus
discuss
specif
diagnost
test
rel
superflu
howev
mani
multipathogen
approach
discuss
herein
includ
virus
panel
everexpand
list
pneumoniacaus
pathogen
time
consum
expens
test
organ
individu
abil
detect
multipl
pathogen
singl
test
therefor
highli
appeal
subject
signific
research
develop
valid
set
respiratori
tract
infect
start
homegrown
multiplex
pcr
assay
varieti
new
platform
develop
speed
pathogen
identif
case
combin
antibiot
sensit
test
focu
multipathogen
detect
tool
find
caus
pneumonia
combin
assay
typic
pathogen
pneumonia
atyp
pathogen
multipathogen
detect
system
gener
categor
specif
design
speed
pathogen
recognit
posit
blood
cultur
eg
includ
system
verigen
gramposit
blood
cultur
nucleic
acid
test
nanospher
northbrook
il
proveit
sepsi
striparray
technolog
mobidiag
espoo
finland
filmarray
biofir
diagnost
salt
lake
citi
ut
design
clinic
sampl
sputum
blood
urin
genexpert
system
alreadi
discuss
worth
note
rang
pathogen
assay
steadili
increas
includ
respiratori
syncyti
viru
methicillinresist
staphylococcu
aureu
clearli
relev
pneumonia
filmarray
anoth
novel
allinon
multiplex
pcr
platform
minim
technic
expertis
requir
turnaround
time
approxim
hour
manual
handl
limit
genexpert
varieti
panel
avail
commerci
avail
respiratori
panel
detect
viral
bacteri
pathogen
perform
respiratori
panel
compar
inhous
pcr
test
favor
result
system
seem
robust
enough
use
routin
clinic
practic
cureti
unyvero
cureti
unyvero
pneumonia
cartridg
detect
bacteri
fungal
pathogen
antibiot
resist
marker
respiratori
sampl
singl
run
approxim
hour
panel
includ
l
pneumophila
pneumonia
specif
perform
data
pathogen
clinic
studi
report
preliminari
studi
critic
ill
patient
found
perform
cureti
unyvero
question
note
system
still
develop
mass
spectrometri
avail
decad
improv
size
speed
cost
brought
technolog
point
use
broadrang
targetspecif
identif
pathogen
pcrelectrospray
ioniz
mass
spectrometri
hold
particular
promis
given
identifi
minut
quantiti
mixtur
nucleic
acid
microbi
isol
directli
clinic
specimen
perform
pcrelectrospray
ioniz
mass
spectrometri
detect
influenza
clinic
sampl
seem
least
good
convent
pcr
assay
singl
studi
taiwan
indic
pcrelectrospray
ioniz
mass
spectrometri
promis
detect
multipl
virus
set
respiratori
tract
infect
done
retrospect
rather
real
time
differ
use
mass
spectrometri
matrixassist
laser
desorptionion
time
flight
mass
spectrometri
malditofm
also
proteinpeptid
diagnost
tool
shown
use
identifi
microorgan
speci
level
malditofm
assess
predominantli
mean
rapidli
identifi
ident
bacteria
bacteri
product
posit
blood
cultur
hour
faster
convent
method
comparison
diagnost
accuraci
malditofm
liquid
chromatographi
ms
influenza
metapneumoviru
respiratori
syncyti
viru
suggest
latter
may
superior
potenti
signific
limit
current
malditofm
larg
mixtur
bacteria
present
occur
commonli
hospitalacquir
pneumonia
ventilatoracquir
pneumonia
sensit
specif
becom
suboptim
nextgener
sequenc
also
known
highthroughput
sequenc
gener
term
use
describ
group
differ
modern
sequenc
technolog
includ
illumina
solexa
san
diego
ca
sequenc
roch
sequenc
ion
torrent
protonpgm
sequenc
thermofish
scientif
waltham
solid
sequenc
thermofish
scientif
waltham
recent
technolog
allow
sequenc
dna
rna
much
quickli
cheapli
previous
use
sanger
sequenc
thermofish
scientif
waltham
date
data
applic
nextgener
sequenc
immedi
clinic
care
particularli
use
diagnos
new
andor
novel
pathogen
avail
assay
technolog
improv
move
reli
serolog
test
diagnos
atyp
viral
pathogen
direct
detect
pathogen
clinic
specimen
start
base
homegrown
pcr
assay
increas
array
commerci
assay
appear
first
singl
pathogen
assay
increasingli
multiplex
test
increas
focu
pointofcar
test
least
rapid
enough
turnaround
time
influenc
initi
clinic
manag
driven
develop
host
new
platform
technolog
like
chang
way
manag
pneumonia
come
decad
